"Venopathy" at work: Recasting neointimal hyperplasia in a new light

Translational Research

Volumn 156, Issue 4, 2010, Pages 216-225

  Yevzlin, Alexander S ^a   Chan, Micah R ^a   Becker, Yolanda T ^a   Roy Chaudhury, Prabir ^a   Lee, Timmy ^a   Becker, Bryan N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOVIRUS VECTOR; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHYMASE; CHYMASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDIFOLIGIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE INHIBITOR; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONOCLONAL ANTIBODY; NANOPARTICLE; OSTEOGENIC PROTEIN 1; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; BRACHYTHERAPY; CANNULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG ELUTING STENT; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; GENE THERAPY; GENE TRANSFER; GRAFT FAILURE; GRAFT OCCLUSION; HEMODIALYSIS; HEMODYNAMICS; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MATHEMATICAL MODEL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; TURBULENT FLOW; ULTRASOUND THERAPY; VASCULAR ACCESS; VEIN DISEASE; VEIN GRAFT; ANIMAL; HYPERPLASIA; INDWELLING CATHETER; INTIMA; PATHOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; VASCULAR PATENCY; VEIN;

ANIMALS; ARTERIOVENOUS FISTULA; CATHETERS, INDWELLING; HUMANS; HYPERPLASIA; RENAL DIALYSIS; TUNICA INTIMA; VASCULAR PATENCY; VEINS;

EID: 77957311284     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.07.004     Document Type: Review

References (59)

1. U.S. Renal Data System USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States 2009 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
2. L.M. Dember, G.J. Beck, and M. Allon Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial JAMA 299 2008 2164 2171 (Pubitemid 351679707)
3. B.S. Dixon, G.J. Beck, and M.A. Vazquez Effect of dipyridamole plus aspirin on hemodialysis graft patency N Engl J Med 360 2009 2191 2201
4. C.J. Chang, P.J. Ko, and L.A. Hsu Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis Am J Kidney Dis 43 2004 74 84
5. P. Roy-Chaudhury, B.S. Kelly, and M.A. Miller Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts Kidney Int 59 2001 2325 2334 (Pubitemid 32467627)
6. P. Roy-Chaudhury, L. Arend, and J. Zhang Neointimal hyperplasia in early arteriovenous fistula failure Am J Kidney Dis 50 2007 782 790 (Pubitemid 47588553)
7. L. Li, C.M. Terry, Y.T. Shiu, and A.K. Cheung Neointimal hyperplasia associated with synthetic hemodialysis grafts Kidney Int 74 2008 1247 1261
8. P. Roy-Chaudhury, V.P. Sukhatme, and A.K. Cheung Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint J Am Soc Nephrol 17 2006 1112 1127
9. R.L. Pisoni Vascular access use and outcomes: results from the DOPPS Contrib Nephrol 137 2002 13 19
10. H.C. Rayner, R.L. Pisoni, and B.W. Gillespie Creation, cannulation and survival of arteriovenous fistulae: data from the dialysis outcomes and practice patterns study Kidney Int 63 2003 323 330
11. P. Roy-Chaudhury, L.M. Spergel, A. Besarab, A. Asif, and P. Ravani Biology of arteriovenous fistula failure J Nephrol 20 2007 150 163 (Pubitemid 47072398)
12. E.J. Mattsson, T.R. Kohler, S.M. Vergel, and A.W. Clowes Increased blood flow induces regression of intimal hyperplasia Arterioscler Thromb Vasc Biol 17 1997 2245 2249
13. M.F. Weiss, V. Scivittaro, and J.M. Anderson Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access Am J Kidney Dis 37 2001 970 980 (Pubitemid 32436569)
14. J.E. Rectenwald, L.L. Moldawer, T.S. Huber, J.M. Seeger, and C.K. Ozaki Direct evidence for cytokine involvement in neointimal hyperplasia Circulation 102 2000 1697 1702
15. P. Budu-Grajdeanu, R.C. Schugart, A. Friedman, C. Valentine, A.K. Agarwal, and B.H. Rovin A mathematical model of venous neointimal hyperplasia formation Theor Biol Med Model 5 2008 2 (Pubitemid 351347427)
16. K.E. Allen, K. Varty, L. Jones, R.D. Sayers, P.R. Bell, and N.J. London Human venous endothelium can promote intimal hyperplasia in a paracrine manner J Vasc Surg 19 1994 577 584 (Pubitemid 24137111)
17. M. Fukasawa, K. Matsushita, and M. Kamiyama The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients Am J Kidney Dis 41 2003 637 642 (Pubitemid 36278381)
18. G.H. Heine, C. Ulrich, U. Sester, M. Sester, H. Kohler, and M. Girndt Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients Kidney Int 64 2003 1101 1107 (Pubitemid 37013849)
19. A. Lazo-Langner, G.A. Knoll, P.S. Wells, N. Carson, and M.A. Rodger The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene Blood 108 2006 4052 4058 (Pubitemid 44913274)
20. C.C. Lin, W.C. Yang, and S.J. Lin Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients Kidney Int 69 2006 165 172
21. J.P. Juncos, M.J. Tracz, and A.J. Croatt Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse Kidney Int 74 2008 47 51
22. C.C. Lin, C.F. Chang, M.Y. Lai, T.W. Chen, P.C. Lee, and W.C. Yang Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients J Am Soc Nephrol 18 2007 985 992 (Pubitemid 46434516)
23. S. Stracke, K. Konner, and I. Kostlin Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas Kidney Int 61 2002 1011 1019 (Pubitemid 34175470)
24. B. Kelly, M. Melhem, and J. Zhang Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model Nephrol Dial Transplant 21 2006 2425 2431 (Pubitemid 44644513)
25. W.D. Paulson, K. Kipiani, N. Beridze, M.V. DeVita, S. Shenoy, and S.S. Iyer Safety and efficacy of locally eluted sirolimus for prolonging AV graft patency (PTFE graft plus Coll-R) - First in man experience J Am Soc Nephrol 19 2008 252A
26. A.W. Hoel, and M.S. Conte Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass Cardiovasc Drug Rev 25 2007 221 234
27. T.N. McAllister, M. Maruszewski, and S.A. Garrido Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study Lancet 373 2009 1440 1446
28. F. Ikeno, J. Lyons, H. Kaneda, M. Baluom, L.Z. Benet, and M. Rezaee Novel percutaneous adventitial drug delivery system for regional vascular treatment Catheter Cardiovasc Interv 63 2004 222 230 (Pubitemid 39313418)
29. S.J. Kim, T. Masaki, R. Rowley, J.K. Leypoldt, S.F. Mohammad, and A.K. Cheung Different responses by cultured aortic and venous smooth muscle cells to gamma radiation Kidney Int 68 2005 371 377 (Pubitemid 43181397)
30. S. Sun, J.J. Beitler, and T. Ohki Inhibitory effect of brachytherapy on intimal hyperplasia in arteriovenous fistula J Surg Res 115 2003 200 208 (Pubitemid 38021909)
31. S. Misra, R. Bonan, T. Pflederer, P. Roy-Chaudhury, and I. Bravo a pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts Kidney Int 70 2006 2006 2013 (Pubitemid 44863390)
32. B.S. Rifkin, U.C. Brewster, J.E. Aruny, and M.A. Perazella Percutaneous balloon cryoplasty: a new therapy for rapidly recurrent anastomotic venous stenoses of hemodialysis grafts? Am J Kidney Dis 45 2005 e27 e32
33. J.I. Rotmans, J.M. Heyligers, and H.J. Verhagen In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts Circulation 112 2005 12 18
34. N. Ikegaya, T. Yamamoto, and A. Takeshita Elevated erythropoietin receptor and transforming growth factor-{beta}1 expression in stenotic arteriovenous fistulae used for hemodialysis J Am Soc Nephrol 5 2000 928 935 (Pubitemid 30241728)
35. S. De Marchi, E. Falleti, and R. Giacomello Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients J Am Soc Nephrol 7 1996 1169 1177 (Pubitemid 27468269)
36. T. Kokubo, N. Ishikawa, and H. Uchida CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas J Am Soc Nephrol 20 2009 1236 1245
37. D. Jin, H. Ueda, and S. Takai Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs J Am Soc Nephrol 16 2005 1024 1034 (Pubitemid 41710313)
38. A. Kizu, D. Medici, and R. Kalluri Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy Am J Pathol 175 2009 1371 1373
39. S. Potenta, E. Zeisberg, and R. Kalluri The role of endothelial-to- mesenchymal transition in cancer progression Br J Cancer 99 2008 1375 1379
40. E.M. Zeisberg, S. Potenta, L. Xie, M. Zeisberg, and R. Kalluri Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts Cancer Res 67 2007 10123 10128 (Pubitemid 350070783)
41. E.M. Zeisberg, O. Tarnavski, and M. Zeisberg Endothelial-to-mesenchymal transition contributes to cardiac fibrosis Nat Med 13 2007 952 961 (Pubitemid 47222040)
42. E. Arciniegas, L.M. Carrillo, J.B. De Sanctis, and D. Candelle Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process Cell Adh Migr 2 2008 17 29
43. C.J. Chang, C.C. Chen, and L.A. Hsu Degradation of the internal elastic laminae in vein grafts of rats with aortocaval fistulae: potential impact on graft vasculopathy Am J Pathol 174 2009 1837 1846
44. S.K.F.F. Burke, A. LaRochelle, and H.V. Mendenhall Local application of recombinant human type 1 pancreatic elastase (PRT-201) to an arteriovenous fistula (AVF) increases AVF blood flow in a rabbit model J Am Soc Nephrol 19 2008 252A
45. R. de Graaf, G. Kloppenburg, and A. Tintu The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model Vascul Pharmacol 50 2009 83 88
46. G. Kloppenburg, R. de Graaf, G. Grauls, C.A. Bruggeman, J.P. van Hooff, and F. Stassen FK778 attenuates cytomegalovirus-enhanced vein graft intimal hyperplasia in a rat model Intervirology 52 2009 189 195
47. Y. Eto, H. Shimokawa, and J. Hiroki Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs Am J Physiol Heart 278 2000 1744 1750 (Pubitemid 30439183)
48. Y. Matsumoto, T. Uwatoku, and K. Oi Long-term inhibition of rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms Arterioscler Thromb Vasc Biol 24 2004 181 186 (Pubitemid 38082431)
49. N. Sawada, H. Itoh, and K. Ueyama Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries Circulation 101 2000 2030 2033 (Pubitemid 30233164)
50. R. Shibata, H. Kai, and Y. Seki Role of rho-associated kinase in neointima formation after vascular injury Circulation 103 2001 284 289 (Pubitemid 32095416)
51. P.-F. Lee, A.T. Yeh, and K.J. Bayless Nonlinear optical microscopy reveals invading endothelial cells anisotropically alter three-dimensional collagen matrices Exp Cell Res 315 2009 396 410
52. J.K.M.D. Liao, M.P. Seto, and K.M.D.P. Noma Rho kinase (ROCK) inhibitors J Cardiovasc Pharmacol 50 2007 17 24
53. H.G. Bone, M.R. McClung, and C. Roux Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density J Bone Miner Res 25 2010 937 947
54. K. Saegusa, N. Ishimaru, and K. Yanagi Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity J Clin Invest 110 2002 361 369 (Pubitemid 34847968)
55. L. Hyun Jung, N. Hye Yeong, L. Byung Ha, K. Dae Joong, K. Jai Young, and P. Jong-sang A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts Biotechnol Prog 23 2007 693 697
56. T.N. Huynh, B.K. Chacko, and X. Teng Effects of venous needle turbulence during ex vivo hemodialysis on endothelial morphology and nitric oxide formation J Biomech 40 2007 2158 2166 (Pubitemid 46977410)
57. M. Begg, F.M. Mo, and L. Offertaler G Protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current J Biol Chem 278 2003 46188 46194 (Pubitemid 37432770)
58. M. Rajesh, P. Mukhopadhyay, and S. Batkai CB2-receptor stimulation attenuates TNF-{alpha}-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion Am J Physiol Heart 293 2007 H2210 H2218 (Pubitemid 47605864)
59. A.S. Yevzlin, B. Guttormsen, M.R. Chan, and G. Gimelli How I do it: directional atherectomy for in-stent restenosis of a PTFE arteriovenous graft Semin Dial 21 2008 266 268